Skip to main content

ESTUDIO EN LOS CAMBIOS INDUCIDOS POR LA DIETA EN EL METILOMA Y EL TRANSCRIPTOMA PARA EVALUAR EL IMPACTO DE LA NUTRICION EN LA SALUD CARDIOMETABOLICA

PCI2018-093009

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos Programación Conjunta Internacional
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

  • Díez-Ricote, Laura
  • San-Cristobal, Rodrigo
  • Concejo, M José
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J Alfredo
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Ros, Emilio|||0000-0002-2573-1294
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • García-Gavilán, Jesús F.
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • Martínez-Urbistondo, Diego
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • García Rodríguez, Antonio
  • Gómez-Bellvert, Nuria
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Bernal-López, Rosa M.
  • Santos-Lozano, José M.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Sorlí, José V.|||0000-0002-0130-2006
  • Murphy, Michelle
  • Gasulla, Griselda|||0000-0003-4018-5786
  • Micó, Víctor
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Goñi Ochandorena, Estibaliz
  • Babio, Nancy|||0000-0003-3527-5277
  • Herraiz, Xavier
  • Ordovás, José M.
  • Daimiel, Lidia|||0000-0001-9898-6629
Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMED-Plus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m 2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (-3.39 and -2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (-0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (-2.93 and -2.78 kg, respectively), BMI (-1.05 and -0.99, respectively), waist circumference (-3.37 and -3.26 cm, respectively), total cholesterol (-4.74 and -4.52 mg/dL, respectively), and LDL cholesterol (-4.30 and -4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (-5.42 and -5.74 mg/dL, respectively). Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at as ISRCTN89898870.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome, The PREDIMED Plus Cohort

  • Martínez-Urbistondo, Diego
  • San Cristóbal, RodrigoSan
  • Villares, Paula
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Ordovás, José M.
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Marcos, Alba
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Bullón Vela, María Vanessa
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Masagué, Marta
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodríguez, Anai
  • Candela-García, Inma
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Juárez, Oscar Lecea
  • Martín, Paco
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Orea, María del Carmen Sayón
  • Megías, Isabel
  • Baltasar, Enric
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Daimiel, Lidia|||0000-0001-9898-6629
To evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). Baseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. Data from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (β 0.64 vs β 0.05 per er-MeDiet adherence point, p< 0.01) and PA (β 0.05 vs β 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. The evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL ().